U.S. Markets close in 1 hr 6 mins

Aeterna Zentaris Inc. (AEZS)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8671-0.01 (-0.90%)
As of 2:25PM EDT. Market open.
People also watch
KERXCYCCCTICGALEAGEN
  • Going to $5 when news about Macrilen are out ?
  • Buy, buy, BUY !!!
    Imagepadfootnprongs21
  • Prepare for BLAST OFF, you FILTHY ANIMALS !!!
    Imagecinema-boheme
  • See why biotech/pharma shareholders are adding this breakthrough wound care to their portfolio.

    • BioLargo’s 10Q states their Advanced Wound Care products are ready, all studies successfully completed, and they expect to file a 510K with FDA in less than 90 days
    • Woundcare market is over $6 Billion with high growth rate
    • Tanya Rhodes, ex VP of Smith & Nephew Wound Care Product Development is leading the BLGO/Clyra Medical 510K filing
    • BLGO/Clyra Medical Wound Care Products promote healing substantially better than competing products, fight infection better than competing products, are effective against resistant microbials, and are low cost
    • Sales could commence in first half of 2018
    • Sales and or licensing agreement/s could be very significant
    • Company is now commercializing several other disruptive products in large markets

    http://www.clyramedical.com

    https://www.sec.gov/Archives/edgar/data/880242/000143774917009469/blgo20170331_10q.htm

    Clyra Medical | Make Life Better
    www.clyramedical.com
  • BIG DEAL TO ACQUIRE UP TO 9 MARKETED PRODUCTS IMMINENT = 20+ BAGGER POTENTIAL !!!
    AQSZF (MC $11 M) is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $11 Million ,this unknown stock is definitely one of the cheapest Biotech in the sector .Stock should be at minimum $2+ right now .

    Market Cap :US$ 11 Million
    Cash $4.1 Million << enough untill mid 2018
    Price 0.18

    MUST WATCH to realize the MONSTER POTENTIAL HERE
    https://www.dukascopy.com/tv/en/view/204408#00

    Presentation
    http://www.aequuspharma.ca/Investors/AQS%20investor%20November%202016_web.pdf

    Operational profitability estimated in 2017

    File for CDN approval of Topiramate XR in 1H 2017

    File for CDN approval of Oxcarbazepine XR in 1H 2017

    Additional Product Deals in 2017

    Partnership for AQS1301 in 2017

    Two products launches to date (Tacrolimus IR and Vistitan™)

    3 long-acting, transdermal programs in development, on track to file NDA in 2018

  • Let's GO you HOGS!
    Buy, buy, BUY !!!
    Imagenakamorijuan
  • Buying at 84 yesterday . I am not buying anymore tell News. Good luck. New Drug looks good.
  • stinking carcass of a dead company.
  • Another 52 week low in the making!!!
  • fake company
  • Fake up and will give back the up by Friday!!
  • you think to hold not to sell now
  • Let's GO you SWINE!
    Buy, buy, BUY !!!
    Imageletsripthat
  • $18M cash, no debt and Macrilen close to approval 😀
  • HERE COMES THESCARYSCARY CRASH BELW $1 CANADAIN
  • Fast decline to a dime. Will AEZS fold up or start another quadruple reverse split to stay in business? There is always a sucker born every second, like my good friend OIL, who predicted a stellar result and urged others to increase their position so that they will not miss the opportunity of a lifetime.
  • Dud up. Back down tomorrow .
  • Can't sustain an up!!! Fake up , real down!!!!
  • I lost almost $30,000 from this company.
    Stay away from Aeterna Zentaris Inc. David Dodd is a very bad guy, he's able to throw your money through the window anytime. Don't invest even a penny to this company, let it be disappeared in the market
  • Huge upside after hours 😃